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Abstract
Background: Respiratory infections in early life are associated with an increased risk of developing asthma but there is little
evidence on the role of infections for onset of asthma in adults. The objective of this study was to assess the relation of the
occurrence of respiratory infections in the past 12 months to adult-onset asthma in a population-based incident case-
control study of adults 21–63 years of age.
Methods/PrincipalFindings: We recruited all new clinically diagnosed cases of asthma (n=521) during a 2.5-year study
period and randomly selected controls (n=932) in a geographically defined area in South Finland. Information on
respiratory infections was collected by a self-administered questionnaire. The diagnosis of asthma was based on symptoms
and reversible airflow obstruction in lung function measurements. The risk of asthma onset was strongly increased in
subjects who had experienced in the preceding 12 months lower respiratory tract infections (including acute bronchitis and
pneumonia) with an adjusted odds ratio (OR) 7.18 (95% confidence interval [CI] 5.16–9.99), or upper respiratory tract
infections (including common cold, sinusitis, tonsillitis, and otitis media) with an adjusted OR 2.26 (95% CI 1.72–2.97).
Individuals with personal atopy and/or parental atopy were more susceptible to the effects of respiratory infections on
asthma onset than non-atopic persons.
Conclusions/Significance: This study provides new evidence that recently experienced respiratory infections are a strong
determinant for adult-onset asthma. Reducing such infections might prevent onset of asthma in adulthood, especially in
individuals with atopy or hereditary propensity to it.
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Introduction
Asthma is a chronic inflammatory disease of the airways
characterized by reversible airflow obstruction [1]. It is among the
mostcommonchronicdiseasesinworking-age adultswith anaverage
prevalence of 7.5% in Finland [2] and 7.3% in United States [3].
Respiratory infections may play a role in the etiology of asthma.
Children who experience viral respiratory infections in early life
are more likely to develop asthma later in childhood [4–7].
However, there is little data on the role of infections for onset of
asthma in adults. Serologic evidence of chronic Chlamydia
pneumoniae infection has been linked to adult asthma [8,9], but
acute respiratory infections as determinants of adult-onset asthma
have not been studied. However, there are plausible mechanisms
by which infectious agents could contribute to induction of asthma
[10,11]. Respiratory infections cause airway epithelial damage and
airway inflammation and initiate immune responses that further
enhance airway inflammation.
The objective of this study was to assess the relation between
occurrence of respiratory infections in the past 12 months and
onset of adult asthma in a population-based incident case-control
study of a working age population. In addition, potential
interaction between atopy and infections for the adult-onset
asthma was evaluated.
Methods
Study design
This study was a population-based incident case-control study.
The source population consisted of adults 21 to 63 years of age
living in the Pirkanmaa Hospital District, a geographically defined
administrative area in South Finland (population 440 913 in
1997). We recruited all the new cases of asthma during a 2.5-year
study period and randomly selected controls from the source
population. All study subjects signed an informed consent form.
The study was approved by the ethics committees of the Finnish
Institute of Occupational Health and the Tampere University
Hospital.
Definition and selection of cases
We recruited systematically all the new cases of asthma 1997–
2000 at all health care facilities diagnosing asthma in the
Pirkanmaa Hospital district, including the Department of
Pulmonary Medicine at the Tampere University Hospital, offices
of the private-practicing pulmonary physicians in the region as
well as public health care centers. As an additional route of case
recruitment, the National Social Insurance Institution of Finland
invited all patients, who had received reimbursement rights for
asthma medication during our study period, but had not yet
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Table 1 [2,12–19].
The medical records of all cases were checked, and only those
with no previously diagnosed asthma or long-term use of any
asthma medication were included in the study to ensure that the
cases had asthma diagnosed for the first time at recruitment. At the
Tampere University Hospital, cases were recruited even before the
diagnosis (at their first visit due to suspected asthma) and the
diagnosis was then verified in clinical examinations. A total of 521
cases participated (response rate 86%).
Selection of controls
The controls were randomly drawn from the source population
using the national population registry, which has full coverage of
the population. The general eligibility criteria were applied for
controls (living in Pirkanmaa, age 21–63 years). Recruitment of
controls took place by a letter at six-month intervals throughout
the study period. A total of 1016 subjects participated in the study
(response rate 80%). Previous or current asthma was reported by
76 (7.5%), six persons were older than 64 years and two returned
incomplete questionnaire. After excluding these persons, our study
population included 932 controls.
Methods
Questionnaire
The study subjects answered a self-administered questionnaire
[2,13,15–17,19–21] that included six sections: 1) personal
characteristics, 2) health information and family history of atopic
diseases, 3) active smoking and secondhand tobacco smoke (SHS)
exposure, 4) occupation and work environment, 5) home
environment, and 6) dietary questions.
Lung function measurements
The same diagnostic protocol was applied for all patients with
suspicion of asthma (Table 1). The spirometry and bronchodila-
tion test were recorded with a pneumotachograph spirometer
using disposable flow transducer (Medikro 905, Medikro, Kuopio,
Finland) according to the standards of the American Thoracic
Society [22]. The details of this and other lung function
measurements are given elsewhere [2,12]. Presence of obstruction
was judged using the reference values derived from the Finnish
population [23].
Assessment of the occurrence of respiratory infections
Occurrence of respiratory infections was assessed based on the
following question: How often did you experience the following infections
during the past 12 months and the past 3 months? The list of infections
included common cold, tonsillitis, sinusitis, otitis media, acute
bronchitis, and pneumonia. The infections were categorized
according to at least one infection ($1) versus no infection (the
reference), except for common colds according to at least two
infections ($2) versus zero to one infection (the reference).
Respiratory infections were classified as lower respiratory tract
infections (LRTI; including acute bronchitis, and pneumonia) and
upper respiratory tract infections (URTI; including common cold,
tonsillitis, sinusitis, and otitis media).
Statistical methods
We used exposure odds ratio (OR) with 95% confidence
interval (CI) derived from logistic regression models to quantify the
relations between occurrence of infections and the risk of asthma.
Sex, age, education (as an indicator of socio-economic status),
personal smoking, mold problems in the home or at work,
exposure to SHS in the home or at work, and any history of pets in
the home were adjusted for as covariates.
We also studied independent and joint effects of both personal
allergic disease and parental allergic disease and LRTIs by
comparing the risk of asthma in four exposure categories: (1) no
personal/parental allergy and no LRTIs during the past 12
months (the reference category); (2) personal/parental allergy and
no LRTIs; (3) no personal/parental allergy but experienced
LRTIs in past 12 months; and (4) personal/parental allergy and
LRTIs. ORs were calculated by contrasting each of the three
exposure categories with the reference category. Estimates for the
independent effects and joint effect were derived from the same
logistic regression model, adjusting for the covariates. Joint effects
were assessed on additive scale from these models.
Personal allergy was defined as a history of allergic rhinitis or
dermatitis diagnosed by a doctor. Parental allergy was defined as a
history of maternal or paternal asthma, hay fever, allergic eczema,
or allergic conjunctivitis.
Table 1. Diagnostic criteria for asthma.
1. Occurrence of at least one asthma-like symptom: prolonged cough, wheezing, attacks of or exercise-induced dyspnea, or nocturnal cough or
wheezing
and
2. Demonstration of significant reversibility in airways obstruction in lung function investigations:
Significant improvement in response to short-acting bronchodilating medication in a bronchodilator test after baseline spirometry or at the end of methacholine
challenge. The criteria for significant changes were [12]: FEV1$15%, FVC$15%, PEF$23%
and/or
$20% daily variation
a and/or $15% improvement
a in response to short-acting bronchodilating medication during at least two days in a 2-week diurnal PEF monitoring
and/or
Significant improvement in spirometric lung function (for % criteria see above)
and/or
$20% improvement in the average PEF level in response to a 2-week oral steroid treatment
FEV1=forced expiratory volume in one second; FVC=forced vital capacity; PEF=peak expiratory flow.
aCalculated according to the standard practice of the Tampere University Hospital: maximum daily variation=(highest PEF value during the day – lowest PEF value
during the day)/highest PEF value during the day; bronchodilator response=(highest PEF value after bronchodilating medication – highest PEF value before
medication)/highest PEF value before medication.
doi:10.1371/journal.pone.0027912.t001
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(SAS Institute Inc., Cary, NC, USA). A graphic was prepared
using the free software package R (R Development Core Team,
2006).
Results
Respiratory infections and the risk of asthma
Characteristics of the cases and controls are presented in
Table 2. Table 3 shows that cases of adult-onset asthma had
experienced more commonly both LRTIs and URTIs in the past
12 months compared to controls (35.8% vs. 7.3% and 33.8% vs.
17.8%, respectively). The risk of asthma onset was significantly
increased in relation to LRTIs (adjusted OR 7.18; 95% CI: 5.16–
9.99) and URTIs (adjusted OR 2.26; 95% CI: 1.72–2.97) in the
past 12 months. Significant increases of asthma risk were also
detected when infections were considered separately, i.e. acute
bronchitis, pneumonia, common cold, sinusitis, and otitis media.
Only the adjusted OR for tonsillitis did not reach significance. We
evaluated exposure-response patterns by estimating ORs of
asthma according to increasing number of infections compared
to no (LRTIs) or zero to one infections (URTIs) in the past 12
months. Figure 1 illustrates a clear exposure-response relation for
LRTIs (trend test: Wald Chi-square 146.8, P,0.0001) and a
suggestive exposure-relation for URTIs (trend test: Wald Chi-
square 3.59, P=0.0581).
Both LRTIs and URTIs were also more common in cases than
controls when experienced during the past three months (9.4% vs.
2.6% and 44.4% vs. 34.8%, respectively). Adjusted ORs were 4.03
(95% CI: 2.35–6.92) for LRTIs and 1.51 (95% CI: 1.19–1.92) for
URTIs. When analyzed according to each infection separately, all
other respiratory infections in the past 3 months significantly
increased the risk of adult-onset asthma, expect tonsillitis
(altogether only 25 episodes of tonsillitis were reported). An OR
for pneumonia could not be calculated, because only two
pneumonias were reported in the last three months, but both of
these were among asthma cases (Table 3).
Joint effect of LRTIs and allergic diseases
We analyzed the joint effect of LRTIs experienced during the
past 12 months and personal allergic diseases (currently or in the
past) on the risk of asthma (Table 4). Subjects with allergic disease
but no LRTIs during the past 12 months had an increased risk for
asthma with an adjusted OR of 1.98 (95% CI: 1.49–2.62),
corresponding to a 98% excess risk compared to nonallergic
subjects with no LRTIs (the reference category). The effect of
LRTIs on adult-onset asthma in nonallergic subjects was also
significant with an OR of 8.49 (95% CI: 5.16–13.97), which
corresponds to a 749% excess risk. In subjects with both allergic
disease and LRTIs the adjusted OR for asthma was 11.38 (95%
CI: 7.25–17.85) corresponding to an excess risk of 1038%. This
suggests a slight synergistic effect of atopy and LRTIs on the
additive scale.
In addition, we analyzed the joint effect of LRTIs and a history
of parental allergic diseases on the risk of asthma (Table 5). Those
subjects with parental allergic disease but no LRTIs during the
past 12 months had a 91% excess risk for asthma (adjusted OR
1.91, 95% CI 1.42–2.58) compared to those with no parental
allergy and no LRTIs (the reference category). The excess risk for
asthma in subjects with LRTIs but no parental allergy was 697%
(adjusted OR 7.97, 95% CI 5.31–11.95). The effect of both
parental allergy and LRTIs suggested a slight synergistic effect on
the additive scale with an OR of 9.97 (95% CI: 5.80–17.13), which
corresponds to an 897% excess risk.
Discussion
Main findings
The results of this study show that occurrence of respiratory
tract infections in the preceding 12 months is a strong
determinant for the onset of adult asthma. This large
population-based incident case-control study that included a
follow-up of 581,000 person-years showed that both upper and
lower respiratory tract infections 12 months prior to the
asthma-onset are significant determinants of asthma in a
working age population. Recently experienced LRTIs, includ-
ing acute bronchitis and pneumonia, were associated with an
especially high OR for asthma. There was evidence for an
exposure-response relation: the asthma risk increased with an
increasing number of both LRTIs and URTIs. A significant
increase in asthma-onset risk wass e e ni na s s o c i a t i o nt oa l lt y p e s
of respiratory infections. The only exception to this consistent
pattern was occurrence of tonsillitis.
There are plausible biological pathways that could underlie
these observations. Besides microbial destruction, immune system
Table 2. Characteristics of the study population.
Characteristic Cases Controls
N( % ) N( % )
Total 521 932
Sex Male 175 (33.6) 346 (66.4)
Female 438 (47.0) 494 (53.0)
Age (years) 21–29 108 (20.7) 141 (15.1)
30–39 107 (20.5) 224 (24.0)
40–49 125 (24.0) 254 (27.3)
50–59 140 (26.9) 240 (25.8)
60–64 41 (7.9) 73 (7.8)
Education
a No vocational schooling 107 (20.6) 154 (16.6)
Vocational course 89 (17.2) 104 (11.2)
Vocational institution 149 (28.7) 271 (29.2)
College-level education 113 (21.8) 261 (28.1)
University or corresponding 61 (11.8) 138 (14.9)
Smoking
b No 239 (46.1) 487 (52.4)
Ex 133 (25.7) 203 (21.8)
Current 146 (28.2) 240 (25.8)
Pets Never 155 (29.8) 316 (33.9)
Past 12 months 10 (1.9) 31 (3.3)
.1 year ago 356 (68.3) 585 (62.8)
Personal allergy
c Never 218 (41.8) 555 (59.6)
Current or in the past 303 (58.2) 377 (40.6)
Parental atopic diseases 186 (35.7) 204 (21.9)
SHS in the workplace 89 (17.1) 130 (13.9)
SHS in the home 30 (5.9) 52 (5.6)
Visible mold or mold odor in the home 70 (13.4) 118 (12.7)
Visible mold or mold odor in the workplace 70 (13.4) 99 (10.6)
SHS=secondhand tobacco smoke.
aInformation on education was missing for 6 subjects.
bInformation on smoking was missing for 5 subjects.
cRhinitis or dermatitis.
doi:10.1371/journal.pone.0027912.t002
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inflammation of the airways and tissue damage. Recently, Kim
et al. [10] introduced a mouse model that provided new evidence
of how chronic lung disease may develop after infection with a
respiratory virus. They infected mouse with a parainfluenza virus
Sendai, which is similar to common human respiratory viruses. An
acute immune defense against infection was followed by a chronic
inflammatory response, where activation of natural killer T cells
and macrophages in the lung promoted persistent production of
IL-13. Persistent IL-13 then caused chronic mucous cell
metaplasia and airway hyperreactivity. They also showed that
similar innate immune axis operated in humans with asthma and
chronic obstructive pulmonary disease. Thus, the innate immune
system may have a pathogenic role in asthma onset after
respiratory infection. So respiratory infections could act as the
primary inducers of inflammation leading to the development of
asthma, or they may act as triggers of onset in subjects already
experiencing inflammation due to other factors, such as environ-
mental exposures.
The risk of asthma related to both LRTIs and URTIs was
stronger when assessing occurrence of infections in the past 12
months as compared to infections in the past 3 months. This could
be explained partly by the smaller number of infections
experienced in the past 3 months, so the estimates for the latter
may be less stable. On the other hand, the stronger effect of
infections in the past year could be compatible with a causal
influence, as a chronic inflammatory response induced by an
infectious agent could be expected to need more than three
months to become severe enough to cause a clinical disease with
symptoms and measurable changes in lung function. Thus, the
past 12 months captures better the relevant time period for
induction of asthma than the past 3 months.
We used a history of parental allergic diseases as a measure of
hereditary propensity to allergy. Consistently with previous
findings, parental allergy was an independent determinant of
asthma onset [13]. In addition, the results showed that a
combination of parental allergy and LRTIs had a synergistic
effect on asthma onset on the additive scale. Interestingly, the
occurrence of LRTIs was a stronger independent determinant for
onset of asthma than the history of parental allergy alone. Also
personal allergy was related to asthma, and a combination of
personal allergy and LRTIs had a synergistic effect on asthma-
onset. These findings suggest that subjects with personal allergy
or hereditary propensity to allergy are more susceptible to the
effects of LRTIs on asthma risk. Similar results have been
reported in children [24–26]. In those studies the highest risk of
asthma was seen in children who were both atopic and
experienced early LRTIs. Atopy and LRTIs seem to be
independent determinants of asthma onset suggesting different
inflammatory pathways. However, an interaction of these
disparate inflammatory stimuli has a synergistic effect on asthma
risk.
Overall, our results suggest that reducing occurrence of
respiratory infections in adults could prevent onset of asthma,
especially in individuals with atopic diseases or a hereditary
propensity to it. This could have major public health impact as
asthma is among the most common chronic diseases in working-
a g ea d u l t s .P r e v e n t i o no fc o m m o nr espiratory infections receives
surprisingly little attention in current public health agendas. A
question worth studying in the future is whether active
Table 3. Occurrence of respiratory infections in the past 12 months and in the past 3 months and the risk of adult-onset asthma.
Infection ($1 infections) Cases Controls
N (%) N (%) Crude OR (95% CI) Adjusted OR (95% CI)
a
Total
b 521 932
During the past 12 months
Lower respiratory tract infections 182 (35.8) 65 (7.3) 7.10 (5.20–9.68) 7.18 (5.16–9.99)
Acute bronchitis 174 (34.6) 64 (7.2) 6.85 (5.01–9.37) 7.03 (5.04–9.81)
Pneumonia 20 (3.9) 5 (0.6) 7.27 (2.71–19.47) 6.46 (2.37–17.63)
Upper respiratory tract infections 172 (33.8) 159 (17.8) 2.36 (1.84–3.03) 2.26 (1.72–2.97)
Common cold
c 258 (50.9) 297 (33.2) 2.08(1.67–2.60) 2.11 (1.65–2.69)
Tonsillitis 36 (7.1) 40 (4.5) 1.63 (1.02–2.59) 1.61 (0.99–2.62)
Sinusitis 140 (27.5) 109 (12.2) 2.73 (2.07–3.61) 2.64 (1.95–3.58)
Otitis media 39 (7.7) 34 (3.8) 2.10 (1.31–3.37) 2.09 (1.27–3.43)
During the past 3 months
Lower respiratory tract infections 48 (9.4) 23 (2.6) 3.94 (2.37–6.56) 4.03 (2.35–6.92)
Acute bronchitis 47 (9.2) 23 (2.6) 3.85 (2.31–6.42) 3.95 (2.29–6.79)
Pneumonia 2 (0.4) 0 (0) - -
Upper respiratory tract infections 226 (44.4) 311 (34.8) 1.50 (1.20–1.87) 1.51 (1.19–1.92)
Common cold 197 (38.7) 289 (32.3) 1.32 (1.05–1.66) 1.32 (1.03–1.68)
Tonsillitis 9 (1.8) 16 (1.8) 0.99 (0.43–2.25) 1.03 (0.44–2.44)
Sinusitis 62 (12.2) 40 (4.5) 2.96 (1.96–4.48) 3.08 (1.98–4.78)
Otitis media 13 (2.6) 10 (1.1) 2.32 (1.01–5.32) 2.52 (1.01–6.29)
aAdjusted for sex, age, education, smoking, SHS exposure (work/home), pets, and exposure to mold (work/home).
bTotal number of cases and controls, information on infections was missing for 50 subjects.
c$2 infections.
doi:10.1371/journal.pone.0027912.t003
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of asthma.
Validity of results
In this study a high proportion of all new asthma cases in a
geographically defined area were recruited by the health case
system and with the help of the National Social Insurance
Institution (response rate 86%). The response rate among controls
was also relatively high (80%). Thus, any major selection bias is
unlikely in this study population.
Asthma was defined on the basis of the occurrence of asthma
symptoms and objective findings in extensive lung function
measurements performed in accordance with the national
guidelines (Table 1). This reduces misclassification of the outcome.
Information about the frequency and type of respiratory
infections during the past 12 months and past 3 months was
Table 4. Joint effect of LRTIs ($1 infections) experienced
during the past 12 months and personal allergic diseases
(currently or in the past) on the risk of asthma.
Allergy LRTI
Crude OR
(95% CI)
Adjusted OR
(95% CI)
a
Excess
risk (%)
No No 1 1
Yes No 1.93 (1.49–2.50) 1.98 (1.49–2.62) 98
No Yes 7.65 (4.81–12.16) 8.49 (5.16–13.97) 749
Yes Yes 11.69 (7.63–17.90) 11.38 (7.25–17.85) 1038
aAdjusted for sex, age, education, smoking, SHS exposure (work/home), pets,
and exposure to mold (work/home).
doi:10.1371/journal.pone.0027912.t004
Figure 1. Exposure-response patterns for LRTIs and URTIs in the past 12 months. X axis shows increasing number of infections (reference
category: no infections for LRTIs and zero to one infections for URTIs) and Y axis shows logarithmic ORs with 95% confidence intervals for asthma
onset.
doi:10.1371/journal.pone.0027912.g001
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may include some misclassification. If both cases and controls tend
to misreport their infections to some degree, this would lead to an
underestimate of the real effect. If being diagnosed with asthma
would influence the recall of respiratory infections so that these
subjects would recall more infections, an information bias could
take place leading to overestimation of the risk. However, it is
unlikely that such bias would lead to so strong increases in risk that
were observed in this study. In addition, this study aimed initially
to investigate occupational exposures and asthma, so no special
attention was paid to infections as potential determinants.
Furthermore, the majority of the cases filled in the questionnaire
before the diagnosis of asthma was made. We did not analyze
specific infectious agents, but this would be interesting to study in
the future.
In the multivariate analyses, all the relations were adjusted for a
number of potential confounders in order to eliminate these
factors as potential explanations for our results.
Synthesis with previous knowledge
The role of respiratory infections in exacerbations of asthma has
been established in both children and adults [6,27–29], but the
present study is the first one describing the role of acute respiratory
infections in the onset of adult asthma. Our results are consistent
with previous studies that have shown an increased risk of asthma
onset in relation to respiratory infections in children [4,6].
Lemanske et al. [7] and Jackson et al. [5] reported birth-cohort
studies of children who were at high risk for asthma, and showed
that wheezing episodes with a viral cause experienced during the
first three years of age predicted a significant risk of asthma at six
years of age. Another birth cohort study by Nafstad et al. [30]
showed that respiratory infections in the first year of life were
linked to increased risk of having bronchial obstruction at the age
of two and asthma at the age of four. Consistently with present
results in adults, the risk of asthma was related especially to lower
respiratory infections.
Conclusions
We present here new evidence that recently experienced
respiratory tract infections are a strong determinant for the onset
of adult asthma. A strongly increased risk of asthma was detected
especially in relation to lower respiratory tract infections, but all
types of respiratory infections studied, i.e. common cold, sinusitis,
otitis, acute bronchitis, and pneumonia increased the risk of
asthma onset. This could mean that reducing occurrence of
respiratory infections might prevent onset of asthma in adulthood,
especially in individuals with an atopic disease or hereditary
propensity to it.
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